Not recruiting
Advanced systemic mastocytosis
Not recruitingInvestigationalNo placebo
Study on the Safety and Effectiveness of Bezuclastinib for Patients with Advanced Systemic Mastocytosis
InvestigationalNo placebo
- Disease:Advanced systemic mastocytosis
- Substances:3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide
- Sponsor:Cogent Biosciences Inc.
